An observational study in Asthma in Children, sponsored by University Hospital, Rouen. Not yet recruiting at 3 sites in France. Open to participants aged 24 Months to 71 Months. Per ClinicalTrials.gov, last updated 2025-10-02.
Sponsored by University Hospital, Rouen · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 296 studies in Asthma with a site in France — 44 open to participants now, 57 under way, 8 of them phase 3. Asthma · France.
Among the 296 studies in Asthma with a site in France, this one is the 37th largest by planned enrollment of the 92 observational ones that give a count, is one of 12 that started in 2025, is one of 92 observational ones, reaches primary completion later than 24 of the 56 other live ones, and was the 281st registered.
4,850 studies on the registry are indexed under Asthma; 604 are open to participants now.
Browse Asthma studies →44 of the 296 studies in Asthma with a site in France are open now. Recruiting first, the newest first:
Novartis Pharmaceuticals · Sites in France, Argentina, Germany and 7 more countries
Ages 12–17
Assistance Publique Hopitaux De Marseille · Sites in France
Ages 18+
AstraZeneca · Sites in France, United States, Argentina and 11 more countries
Ages 6+
Sanofi · Sites in France, United States, Canada and 3 more countries
Ages 6+
University Hospital, Montpellier · Sites in France
Ages 8–12
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 416 Asthma studies recruiting now, 141 (34%) set no upper age limit and 204 (49%) stop at 75 or younger; 146 take children under 18; 105 take healthy volunteers.
This study: 24 Months to 71 Months · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
296 studies; the count open now beside each. This study's row is marked.
First in 1990; this study’s year is marked. 12 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 300 is above the median of 159 across 1,254 observational studies indexed under Asthma.
Median enrollment 209 across the 204 interventional studies, 137 across the 92 observational. Of the 221 that completed or were terminated, 85 (38%) have results posted.
This tab as a report to print or save as PDF → With an account.
147 of 296 have an industry lead sponsor. The 10 most frequent:
University Hospital, Rouen is the lead sponsor of 418 studies on the registry; 106 are open to participants now.
University Hospital, Rouen has 3 studies filed under Asthma — fewer than ten, so there is no comparison to draw.
10 of the studies in Asthma with a site in France that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05692180Phase 3AstraZenecaA Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma | 2026-12-23 |
| NCT06473779Phase 3AstraZenecaOpen-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma. | 2027-06-25 |
| NCT06988358University Hospital, RouenEarly Identification of Children With Asthma | 2026-12-31 |
| NCT05734261University Hospital, MontpellierForced Oscillations Technique During a Metacholine Test in Children | 2027-02-06 |
| NCT04763447Assistance Publique - Hôpitaux de ParisShort Treatment with Omalizumab for Severe Asthma | 2027-05-20 |
Add all 10 to your calendar (.ics) → With an account.
Among the 296 studies in Asthma with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
GPs are one of the key players in the early diagnosis of chronic diseases, such as asthma in pre-school children, by detecting symptoms of illness as early as possible. Patient health data is collected on an ongoing basis in GPs' electronic medical records, but remains little exploited despite its potential.
Helping GPs to identify asthma in pre-school children, based on the information in their electronic medical records, could help them to diagnose the condition early and thereby reduce the morbidity and mortality associated with it.
An algorithm developed and evaluated in a primary care data warehouse should help GPs to identify children with a diagnosis of asthma at an early stage.
Asthma is the most common chronic disease affecting children. It is defined by repeated episodes of heterogeneous respiratory symptoms, such as wheezing, breathlessness, chest tightness and cough, which vary in time and intensity, as well as variable expiratory flow limitation. Asthma in pre-school children corresponds to asthma in children under the age of 6.
Diagnosis in children is particularly complex, due to the difficulty of performing respiratory tests such as spirometry, and the fact that symptoms often diminish with age. Diagnosis is based on a number of factors, including response to treatment and the absence of a differential diagnosis. Although asthma in pre-school children is frequent and sometimes serious, it is under-diagnosed and not optimally treated. GPs are among the key players in the early diagnosis of chronic diseases, by detecting symptoms of illness as early as possible. Patient health data is collected on an ongoing basis in GPs' electronic medical records, but remains little exploited despite its potential.
Helping GPs to identify asthma in pre-school children, based on the information in their electronic medical records, could help them to diagnose the condition at an early stage, thereby reducing the morbidity and mortality associated with it.
An algorithm, developed and evaluated in a primary care data warehouse, should help GPs to identify children with a diagnosis of asthma at an early stage.
Children aged 2 to 5 followed for health reasons
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
150 medical files of children identified by the algorithm as having asthma will be randomly selected for expert appraisal.
150 medical files of children not identified by the algorithm as having asthma will be randomly selected for expert appraisal.
Evaluating the sensitivity of an algorithm for the early identification of extracurricular children with asthma
Evaluate the algorithm's predictions against expert opinion to estimate the Sensitivity of the algorithm with a minimum accuracy of +/- 0.10 at an α risk of 5%, based on the following variables (number of true positives, number of false positives, number of true negatives and number of false negatives)
Time frame: At enrollment visit
Assessing the specificity of an algorithm for the early identification of pre-school children with asthma
Evaluate the algorithm's predictions against expert opinion to estimate the Specificity of the algorithm with a minimum accuracy of +/- 0.10 at an α risk of 5%, based on the following variables (number of true positives, number of false positives, number of true negatives and number of false negatives)
Time frame: At enrollment visit
Assessing the positive predictive value of an algorithm for the early identification of pre-school children with asthma
Evaluate the algorithm's predictions against expert opinion to estimate the positive predictive value of the algorithm with a minimum accuracy of +/- 0.10 at an α risk of 5%, based on the following variables (number of true positives, number of false positives, number of true negatives and number of false negatives)
Time frame: At enrollment visit
Assessing the negative predictive value of an algorithm for the early identification of pre-school children with asthma
Evaluate the algorithm's predictions against expert opinion to estimate the negative predictive value of the algorithm with a minimum accuracy of +/- 0.10 at an α risk of 5%, based on the following variables (number of true positives, number of false positives, number of true negatives and number of false negatives)
Time frame: At enrollment visit
Reliability of an algorithm for the early identification of children of pre-school age (2 years)
Evaluate the algorithm's predictions against expert opinion to estimate the negative predictive value, the positive value, the specificity and the sensibilité of the algorithm with a minimum accuracy of +/- 0.10 at an α risk of 5%, based on the following variables (number of true positives, number of false positives, number of true negatives and number of false negatives) of children of pre-school age (2 years) with asthma
Time frame: At enrollment visit
Reliability of an algorithm for the early identification of children of pre-school age (4 years)
Evaluate the algorithm's predictions against expert opinion to estimate the negative predictive value, the positive value, the specificity and the sensibilité of the algorithm with a minimum accuracy of +/- 0.10 at an α risk of 5%, based on the following variables (number of true positives, number of false positives, number of true negatives and number of false negatives) of children of pre-school age (4 years) with asthma
Time frame: At enrollment visit
Reliability of an algorithm for the early identification of children of pre-school age (5 years and 11 months)
Evaluate the algorithm's predictions against expert opinion to estimate the negative predictive value, the positive value, the specificity and the sensibilité of the algorithm with a minimum accuracy of +/- 0.10 at an α risk of 5%, based on the following variables (number of true positives, number of false positives, number of true negatives and number of false negatives) of children of pre-school age (5 years and 11 months) with asthma
Time frame: At enrollment visit
Population with asthma identified by the algorithm
Describe the population identified by the algorithm and the experts, and compare it with patients already identified as having asthma (in their history) by their GP.
Time frame: At enrollment visit
Number of asthma patients newly detected thanks to the algorithm
Estimate the number of asthma patients newly detected thanks to the algorithm who were not initially detected.
Time frame: At enrollment visit
Estimate of the percentage of asthma patients identified using this algorithm who were not initially identified by their GPs
Number of patients already identified by their GP
Time frame: At enrollment visit
Estimate of the percentage of asthma patients identified using this algorithm who were not initially identified by their GPs
Number of patients newly identified by the algorithm and the expert group
Time frame: At enrollment visit
Plan to share: No — The data provided will be the property of the sponsor and will be used solely for its own research activities.
No publications or documents are linked to this record.
Start is estimated for Dec 2025; primary completion for Dec 2026, 12 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.